• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Safety of using bacteriophages as a sanitizing agent based on inflammatory responses in rats.基于大鼠炎症反应评估将噬菌体用作消毒剂的安全性。
Food Sci Biotechnol. 2016 Feb 29;25(1):355-360. doi: 10.1007/s10068-016-0050-6. eCollection 2016.
2
Bacteriophage therapy for -induced urinary tract infection in rats.噬菌体治疗 - 诱导的大鼠尿路感染。
Future Microbiol. 2023 Apr;18:323-334. doi: 10.2217/fmb-2022-0107. Epub 2023 May 4.
3
Control of in Fresh-Cut Mixed Vegetables Using a Combination of Bacteriophage and Carvacrol.使用噬菌体和香芹酚组合控制鲜切混合蔬菜中的(相关内容缺失,原文此处不完整)
Antibiotics (Basel). 2023 Oct 30;12(11):1579. doi: 10.3390/antibiotics12111579.
4
In vitro evaluation of a novel bacteriophage cocktail as a preventative for bovine coliform mastitis.一种新型噬菌体鸡尾酒作为牛大肠埃希菌性乳腺炎预防剂的体外评价
J Dairy Sci. 2016 Mar;99(3):2053-2062. doi: 10.3168/jds.2015-9748. Epub 2016 Jan 13.
5
Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.噬菌体鸡尾酒疗法及噬菌体与抗生素协同作用有望成为控制多重耐药性尿路致病性大肠杆菌的传统抗生素替代方案。
Virus Res. 2021 Sep;302:198496. doi: 10.1016/j.virusres.2021.198496. Epub 2021 Jun 25.
6
Novel approach of using a cocktail of designed bacteriophages against gut pathogenic E. coli for bacterial load biocontrol.使用定制噬菌体鸡尾酒对抗肠道致病性大肠杆菌以进行细菌载量生物控制的新方法。
Ann Clin Microbiol Antimicrob. 2014 Jul 26;13:39. doi: 10.1186/s12941-014-0039-z.
7
Isolation and Characterization of Lytic Bacteriophages Active against Clinical Strains of and Development of a Phage Antimicrobial Cocktail.针对 和临床株的裂解噬菌体的分离与鉴定及噬菌体抗菌鸡尾酒的开发。
Viruses. 2022 Oct 28;14(11):2381. doi: 10.3390/v14112381.
8
The use of bacteriophages against saprophytic mesophilic bacteria in minimally processed food.噬菌体在轻度加工食品中对腐生嗜温细菌的应用。
Acta Sci Pol Technol Aliment. 2021 Oct-Dec;20(4):473-484. doi: 10.17306/J.AFS.0968.
9
A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.一种噬菌体能有效裂解宿主并抑制其产生抗噬菌体的大肠杆菌菌株。
Appl Microbiol Biotechnol. 2018 Jan;102(2):971-983. doi: 10.1007/s00253-017-8591-z. Epub 2017 Nov 17.
10
Phage cocktail strategies for the suppression of a pathogen in a cross-feeding coculture.用于在交叉喂养共培养中抑制病原体的噬菌体鸡尾酒策略。
Microb Biotechnol. 2020 Nov;13(6):1997-2007. doi: 10.1111/1751-7915.13650. Epub 2020 Aug 19.

引用本文的文献

1
Bacteriophage-Host Interactions and the Therapeutic Potential of Bacteriophages.噬菌体-宿主相互作用及噬菌体的治疗潜力。
Viruses. 2024 Mar 20;16(3):478. doi: 10.3390/v16030478.
2
The applications of animal models in phage therapy: An update.动物模型在噬菌体治疗中的应用:最新进展。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2175519. doi: 10.1080/21645515.2023.2175519. Epub 2023 Mar 19.
3
Isolation of a Novel Jumbo Bacteriophage Effective Against .一种对……有效的新型巨型噬菌体的分离
Front Med (Lausanne). 2020 Feb 28;7:67. doi: 10.3389/fmed.2020.00067. eCollection 2020.
4
Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections.噬菌体治疗细菌感染的优势与局限
Front Pharmacol. 2019 May 8;10:513. doi: 10.3389/fphar.2019.00513. eCollection 2019.
5
Bacteriophage Clinical Use as Antibacterial "Drugs": Utility and Precedent.噬菌体临床应用作为抗菌“药物”:效用和先例。
Microbiol Spectr. 2017 Aug;5(4). doi: 10.1128/microbiolspec.BAD-0003-2016.

本文引用的文献

1
Observation of inflammatory responses in mice orally fed with bacteriophage T7.口服噬菌体 T7 对小鼠炎症反应的观察
J Appl Microbiol. 2014 Sep;117(3):627-33. doi: 10.1111/jam.12565. Epub 2014 Jun 30.
2
Experimental phage therapy against lethal lung-derived septicemia caused by Staphylococcus aureus in mice.实验噬菌体疗法对抗金黄色葡萄球菌引起的致命肺部脓毒症的小鼠。
Microbes Infect. 2014 Jun;16(6):512-7. doi: 10.1016/j.micinf.2014.02.011. Epub 2014 Mar 12.
3
Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin.肠球菌噬菌体 IME-EF1 的特性及其溶菌素。
PLoS One. 2013 Nov 13;8(11):e80435. doi: 10.1371/journal.pone.0080435. eCollection 2013.
4
T4 phage and its head surface proteins do not stimulate inflammatory mediator production.T4 噬菌体及其头部表面蛋白不会刺激炎症介质的产生。
PLoS One. 2013 Aug 16;8(8):e71036. doi: 10.1371/journal.pone.0071036. eCollection 2013.
5
Visualizing a complete Siphoviridae member by single-particle electron microscopy: the structure of lactococcal phage TP901-1.通过单颗粒电子显微镜直观呈现完整的长尾噬菌体科成员:乳球菌噬菌体 TP901-1 的结构。
J Virol. 2013 Jan;87(2):1061-8. doi: 10.1128/JVI.02836-12. Epub 2012 Nov 7.
6
Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice.肠聚集性大肠杆菌定植可支持噬菌在小鼠体内的长期复制。
Environ Microbiol. 2012 Aug;14(8):1844-54. doi: 10.1111/j.1462-2920.2011.02644.x. Epub 2011 Nov 28.
7
In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model.在小鼠感染模型中,噬菌体治疗的成功率与噬菌体的体内生长速率相关性较差。
Antimicrob Agents Chemother. 2012 Feb;56(2):949-54. doi: 10.1128/AAC.05842-11. Epub 2011 Nov 21.
8
The next generation of bacteriophage therapy.下一代噬菌体疗法。
Curr Opin Microbiol. 2011 Oct;14(5):524-31. doi: 10.1016/j.mib.2011.07.028. Epub 2011 Aug 23.
9
In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.T4和T7噬菌体在定殖有大肠杆菌的无菌小鼠体内的复制
Virology. 2009 Oct 10;393(1):16-23. doi: 10.1016/j.virol.2009.07.020. Epub 2009 Aug 21.
10
T4 phages against Escherichia coli diarrhea: potential and problems.针对大肠杆菌性腹泻的T4噬菌体:潜力与问题
Virology. 2009 May 25;388(1):21-30. doi: 10.1016/j.virol.2009.03.009. Epub 2009 Apr 1.

基于大鼠炎症反应评估将噬菌体用作消毒剂的安全性。

Safety of using bacteriophages as a sanitizing agent based on inflammatory responses in rats.

作者信息

Hwang Ji-Yeon, Kim Jung-Eun, Song Yoon-Jae, Park Jong-Hyun

机构信息

1Department of Food Science and Biotechnology, Gachon University, Seongnam, Gyeonggi, 13120 Korea.

2Department of Life Science, Gachon University, Seongnam, Gyeonggi, 13120 Korea.

出版信息

Food Sci Biotechnol. 2016 Feb 29;25(1):355-360. doi: 10.1007/s10068-016-0050-6. eCollection 2016.

DOI:10.1007/s10068-016-0050-6
PMID:30263278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6049376/
Abstract

Use of bacteriophages as sanitizing agents has received much attention. However, safety in humans is debatable. To determine inflammatory immune responses against bacteriophages, rats were treated with a 8 log plaque-forming cocktail of 5 bacteriophages for pathogenic per day for 4 weeks. Food consumption, feeding efficiency, and body weight of rats treated with the cocktail were not different from controls. Phages were not detected in the sera of phage-fed rats with no changes in organ weights. Notable changes were not observed upon histopathological examination of the liver, kidney, and spleen. Pro-inflammatory cytokine mRNA expression, except COX-2 (2.4x increase), remained unaffected after treatment with the phage cocktail. No remarkable changes were observed for levels of 12 pro-inflammatory cytokines in sera. Inflammatory responses in rats orally treated with a phage cocktail were not observed. Bacteriophages for are indicated as immunologically safe in rats.

摘要

将噬菌体用作消毒剂已备受关注。然而,其对人类的安全性存在争议。为确定针对噬菌体的炎性免疫反应,用含5种噬菌体的8个对数噬菌斑形成混合物对大鼠进行处理,以用于致病性治疗,每天一次,持续4周。用该混合物处理的大鼠的食物消耗、进食效率和体重与对照组无异。在喂食噬菌体的大鼠血清中未检测到噬菌体,器官重量也无变化。对肝脏、肾脏和脾脏进行组织病理学检查时未观察到明显变化。用噬菌体混合物处理后,除COX - 2(增加2.4倍)外,促炎细胞因子mRNA表达未受影响。血清中12种促炎细胞因子水平未观察到显著变化。未观察到口服噬菌体混合物的大鼠出现炎症反应。表明用于[此处原文缺失相关内容]的噬菌体在大鼠中具有免疫安全性。